Pulmonary hypertension in COPD: pathophysiology and therapeutic targets

E Zakynthinos, Z Daniil, J Papanikolaou… - Current drug …, 2011 - ingentaconnect.com
The incidence of mild to moderate pulmonary hypertension (PH) is highly prevalent,
reaching to 50% in advanced chronic obstructive pulmonary disease (COPD). However, a …
被引用次数：81 相关文章

Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.

E Zakynthinos, Z Daniil, J Papanikolaou… - Current Drug …, 2011 - europepmc.org
The incidence of mild to moderate pulmonary hypertension (PH) is highly prevalent,
reaching to 50% in advanced chronic obstructive pulmonary disease (COPD). However, a …

Pulmonary hypertension in COPD: pathophysiology and therapeutic targets

E Zakynthinos, Z Daniil… - Current drug …, 2011 - pubmed.ncbi.nlm.nih.gov
The incidence of mild to moderate pulmonary hypertension (PH) is highly prevalent,
reaching to 50% in advanced chronic obstructive pulmonary disease (COPD). However, a …

[引用][C] Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets

E Zakynthinos, Z Daniil, J Papanikolaou… - Current Drug Targets, 2011 - cir.nii.ac.jp
Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …